Investigation into the anti-inflammatory properties of metformin in intervertebral disc cells
- PMID: 35783910
- PMCID: PMC9238278
- DOI: 10.1002/jsp2.1197
Investigation into the anti-inflammatory properties of metformin in intervertebral disc cells
Abstract
Introduction: Intervertebral disc degeneration (IDD) is closely related to heightened inflammation in the annulus fibrosis (AF) and nucleus pulposus (NP) cells in the intervertebral disc. An imbalanced matrix homeostasis has been shown to contribute to disc degeneration and associated discogenic low back pain. Metformin, a diabetes medication, has been noted to exhibit anti-inflammatory properties through upregulation of the AMPK pathway, leading to various anti-inflammatory-related responses in hepatocytes. However, it is still unclear how metformin influences disc cellular response to inflammatory stress and the corresponding mechanism. Hence, the objective of this study is to elucidate the effects of metformin on expression of key pro-inflammatory, catabolic, and anabolic factors within rat AF cells in response to inflammatory stimulation and mechanical tensile stress.
Methods: Five Fischer 344 rats were sacrificed and their spines isolated. AF cells were cultured and plated in flexible silicone membrane-based six-well plates. Wells were split into eight groups and subjected to metformin, IL-1β, mechanical stretch, and combined treatments. Relative gene expressions of MMP-13, COX-2, iNOS, AGC, and Col1 were assessed with quantitative real-time polymerase chain reaction (qRT-PCR), and downstream prostaglandin E2 (PGE2) production was quantified with enzyme-linked immunosorbent assay (ELISA). NF-kB nuclear translocation was also quantified.
Results: Metformin in the presence of the combined stress treatments (M + IL/S) significantly increased Col1, COX-2, and MMP-13 gene expression, decreased PGE2 production compared to IL/S conditions alone. Metformin treatment of cultured rat annulus fibrosus cells significantly reduced the nuclear translocation of NF-κB after 4 h of IL-1β treatment from 43.1% in case of IL-1β treatment down to 26.2% in the case of metformin + IL-1β treatment.
Discussion: The lack of metformin-mediated suppression of inflammatory response in the nonstretch groups indicates that metformin may be enacting its effects through a stretch-dependent manner. These results suggest a foundation for pursuing further research into metformin's potential role as an anti-inflammatory agent for curtailing intervertebral disc degeneration.
Keywords: AMPK pathway; NF‐kB translocation; anti‐inflammatory; anti‐inflammatory therapy; biomechanical profile of intervertebral disc; disc aging; disc mechanics; inflammatory profile of intervertebral disc; intervertebral disc degeneration; metformin therapy.
© 2022 The Authors. JOR Spine published by Wiley Periodicals LLC on behalf of Orthopaedic Research Society.
Conflict of interest statement
None declared.
Figures





Similar articles
-
Maltol ameliorates intervertebral disc degeneration through inhibiting PI3K/AKT/NF-κB pathway and regulating NLRP3 inflammasome-mediated pyroptosis.Inflammopharmacology. 2023 Feb;31(1):369-384. doi: 10.1007/s10787-022-01098-5. Epub 2022 Nov 19. Inflammopharmacology. 2023. PMID: 36401729 Free PMC article.
-
NF-κB Signaling Pathway in Controlling Intervertebral Disk Cell Response to Inflammatory and Mechanical Stressors.Phys Ther. 2016 May;96(5):704-11. doi: 10.2522/ptj.20150045. Epub 2016 Feb 18. Phys Ther. 2016. PMID: 26893504 Free PMC article.
-
Effects of nuclear factor kappa B signaling pathway in human intervertebral disc degeneration.Spine (Phila Pa 1976). 2015 Feb 15;40(4):224-32. doi: 10.1097/BRS.0000000000000733. Spine (Phila Pa 1976). 2015. PMID: 25494317
-
[Relationship between inflammatory cytokines of IL-1β and TNF-α and intervertebral disc degeneration].Zhongguo Gu Shang. 2017 Sep 25;30(9):866-871. doi: 10.3969/j.issn.1003-0034.2017.09.017. Zhongguo Gu Shang. 2017. PMID: 29455492 Review. Chinese.
-
The aging spine: the role of inflammatory mediators in intervertebral disc degeneration.Cell Mol Biol (Noisy-le-grand). 2007 May 30;53(5):4-18. Cell Mol Biol (Noisy-le-grand). 2007. PMID: 17543240 Review.
Cited by
-
The pathogenesis and targeted therapies of intervertebral disc degeneration induced by cartilage endplate inflammation.Front Cell Dev Biol. 2024 Dec 2;12:1492870. doi: 10.3389/fcell.2024.1492870. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39687521 Free PMC article. Review.
-
Metformin prevents the onset and progression of intervertebral disc degeneration: New insights and potential mechanisms (Review).Int J Mol Med. 2024 Aug;54(2):71. doi: 10.3892/ijmm.2024.5395. Epub 2024 Jul 4. Int J Mol Med. 2024. PMID: 38963023 Free PMC article. Review.
-
Mapping knowledge structure and themes trends of non-surgical treatment in intervertebral disc degeneration.Heliyon. 2024 Aug 28;10(17):e36509. doi: 10.1016/j.heliyon.2024.e36509. eCollection 2024 Sep 15. Heliyon. 2024. PMID: 39286189 Free PMC article. Review.
-
The relationship between biomechanical factors and intervertebral disc degeneration: a review.Am J Transl Res. 2025 May 15;17(5):3575-3585. doi: 10.62347/DSJK1156. eCollection 2025. Am J Transl Res. 2025. PMID: 40535657 Free PMC article. Review.
-
Recent Advances in Managing Spinal Intervertebral Discs Degeneration.Int J Mol Sci. 2022 Jun 9;23(12):6460. doi: 10.3390/ijms23126460. Int J Mol Sci. 2022. PMID: 35742903 Free PMC article. Review.
References
-
- Spine: Low Back and Neck Pain/BMUS . The burden of musculoskeletal diseases in the United States. 2021. https://www.boneandjointburden.org/2014‐report/ii0/spine‐low‐back‐and‐ne.... Accessed 6 Aug 2021
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous